C. Garbe

Details der Publikationsliste

Zeitraum

2000 - 2008

Anzahl

22

Co-Autoren

Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG) (2008)

Spieth, K., Kaufmann, R., Dummer, R., Garbe, C., Becker, J. C., Hauschild, A., ...

Background: Combination of temozolomide (TMZ) with nonpegylated interferon alfa is associated with increased efficacy in terms of response rates compared with monotherapy. A multicenter phase II...

Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis (2008)

Garbe, C., Radny, P., Linse, R., Dummer, R., Gutzmer, R., Ulrich, J., ...

Background: More than half of patients with melanoma that has spread to regional lymph nodes develop recurrent disease within the first 3 years after surgery. The aim of the study was to improve...

Correlation with Digital Dermoscopic Images Can Help Dermatopathologists to Diagnose Equivocal Skin Tumours (2006)

Bauer, J., Leinweber, B., Metzler, G., Blum, A., Hofmann-Wellenhof, R., Leitz, N., ...

Background Flares of eczema are attributed to many factors, often with minimal scientific evidence. Objectives Systematically to search, summarize and critically appraise the scientific evidence to...

Correlation with Digital Dermoscopic Images Can Help Dermatopathologists to Diagnose Equivocal Skin Tumours (2006)

Bauer, J., Leinweber, B., Metzler, G., Blum, A., Hofmann-Wellenhof, R., Leitz, N., ...

Background Flares of eczema are attributed to many factors, often with minimal scientific evidence. Objectives Systematically to search, summarize and critically appraise the scientific evidence to...

Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study (2006)

Schadendorf, D, Hauschild, A, Ugurel, S, Thoelke, A, Egberts, F, Kreissig, M, ...

Background: Temozolomide has shown some efficacy in metastatic melanoma and recently received extended approval to treat brain tumours. The purpose of this study was to test a dose-intensified...

Value of the clinical history for different users of dermoscopy compared with results of digital image analysis (2004)

Blum, A., Hofmann-Wellenhof, R., Luedtke, H., Ellwanger, U., Steins, A., Roehm, S., ...

Background The clinical history of a given pigmented lesion could influence the therapeutic decision. Teledermatology and automated image analysis also hold great potential for revolutionizing...

Value of the clinical history for different users of dermoscopy compared with results of digital image analysis (2004)

Blum, A., Hofmann-Wellenhof, R., Luedtke, H., Ellwanger, U., Steins, A., Roehm, S., ...

Background The clinical history of a given pigmented lesion could influence the therapeutic decision. Teledermatology and automated image analysis also hold great potential for revolutionizing...

Clinical and Laboratory Investigations The dermoscopic classification of atypical melanocytic naevi (Clark naevi) is useful to discriminate benign from malignant melanocytic lesions. (2003)

Blum, A., Soyer, H.P., Garbe, C., Kerl, H., Rassner, G., Hofmann-Wellenhof, R.

Background The dermoscopic classification is a useful tool for handling patients with atypical naevi (Clark naevi). Objectives To investigate if the dermoscopic classification of atypical naevi is of...

Clinical and Laboratory Investigations The dermoscopic classification of atypical melanocytic naevi (Clark naevi) is useful to discriminate benign from malignant melanocytic lesions. (2003)

Blum, A., Soyer, H.P., Garbe, C., Kerl, H., Rassner, G., Hofmann-Wellenhof, R.

Background The dermoscopic classification is a useful tool for handling patients with atypical naevi (Clark naevi). Objectives To investigate if the dermoscopic classification of atypical naevi is of...

Naturally Processed Dermcidin-Derived Peptides Do Not Permeabilize Bacterial Membranes and Kill Microorganisms Irrespective of Their Charge

Steffen, H., Rieg, S., Wiedemann, I., Kalbacher, H., Deeg, M., Sahl, H.-G., ...

Dermcidin (DCD) is a recently described antimicrobial peptide, which is constitutively expressed in eccrine sweat glands and transported via sweat to the epidermal surface. By postsecretory...

Naturally Processed Dermcidin-Derived Peptides Do Not Permeabilize Bacterial Membranes and Kill Microorganisms Irrespective of Their Charge

Steffen, H., Rieg, S., Wiedemann, I., Kalbacher, H., Deeg, M., Sahl, H.-G., ...

Dermcidin (DCD) is a recently described antimicrobial peptide, which is constitutively expressed in eccrine sweat glands and transported via sweat to the epidermal surface. By postsecretory...

The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients.

Häffner, A. C., Garbe, C., Burg, G., Büttner, P., Orfanos, C. E., Rassner, G.

The prognostic value of the TNM classifications of the UICC dated 1978 and 1987, was investigated in a population of 2,495 patients who were followed up over the long term. In the case of primary...

Expression of interleukin 10 in human melanoma.

Krüger-Krasagakes, S., Krasagakis, K., Garbe, C., Schmitt, E., Hüls, C., Blankenstein, T., ...

The expression of interleukin 10 (IL-10) mRNA in human malignant melanoma was investigated by reverse transcriptase polymerase chain reaction analysis. Selective expression of IL-10 mRNA in tissues...

Specifically regulated genes in malignant melanoma tissues identified by subtractive hybridization

Hipfel, R, Schittek, B, Bodingbauer, Y, Garbe, C

A polymerase chain reaction (PCR)-based subtractive hybridization technique was used to identify transformation-related genes in malignant melanoma. Melanoma biopsies were compared with tissues of...

Dacarbazine and interferon α with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG)

Hauschild, A, Garbe, C, Stolz, W, Ellwanger, U, Seiter, S, Dummer, R, ...

In several phase II-trials encouraging tumour responses rates in advanced metastatic melanoma (stage IV; AJCC-classification) have been reported for the application of biochemotherapy containing...